Edwards Lifesciences
1,293 hedge funds and large institutions have $45.4B invested in Edwards Lifesciences in 2024 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 463 increasing their positions, 463 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 463 | Existing positions reduced: 463
2% less capital invested
Capital invested by funds: $46.4B → $45.4B (-$1.03B)
7% less call options, than puts
Call options by funds: $276M | Put options by funds: $297M
Holders
1,293
Holding in Top 10
15
Calls
$276M
Puts
$297M
Top Buyers
| 1 | +$348M | |
| 2 | +$204M | |
| 3 | +$137M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$122M |
| 5 |
Swedbank
Stockholm,
Sweden
|
+$109M |
Top Sellers
| 1 | -$224M | |
| 2 | -$179M | |
| 3 | -$128M | |
| 4 |
JP Morgan Chase
New York
|
-$81.7M |
| 5 |
State Street
Boston,
Massachusetts
|
-$67.9M |